Nidan Laboratories And Healthcare Share Price
Start SIP in Nidan Laboratories And Healthcare
Start SIPNidan Laboratories And Healthcare Performance
Day Range
- Low 34
- High 34
52 Week Range
- Low 27
- High 41
- Open Price34
- Previous Close34
- Volume3000
Nidan Laboratories And Healthcare Investment Rating
-
Master Rating:
-
Nidan Laboratories And Healthcare has an operating revenue of Rs. 98.90 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of -10% needs improvement, ROE of -4% is poor and needs improvement. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. It is currently FORMING a base in its weekly chart and is trading around 17% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 27 indicates it belongs to a strong industry group of Medical-Services and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual Cr | 27 | 28 |
| Operating Expenses Annual Cr | 18 | 17 |
| Operating Profit Annual in Cr | 6 | 7 |
| Depreciation Cr | 3 | 3 |
| Interest Annual Cr | 2 | 2 |
| Tax Annual Cr | 1 | 1 |
| Net Profit Annual Cr | -3 | 4 |
Nidan Laboratories And Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- ₹33.66
- 50 Day
- ₹33.70
- 100 Day
- ₹33.66
- 200 Day
- ₹34.35
- 20 Day
- ₹33.58
- 50 Day
- ₹33.84
- 100 Day
- ₹33.84
- 200 Day
- ₹33.58
Nidan Laboratories And Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 33.83 |
| Second Resistance | 34.17 |
| Third Resistance | 34.33 |
| RSI | 48.57 |
| MFI | 56.76 |
| MACD Single Line | -0.02 |
| MACD | 0.05 |
| Support | |
|---|---|
| First Support | 33.33 |
| Second Support | 33.17 |
| Third Supoort | 32.83 |
Nidan Laboratories And Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,000 | 300,000 | 100 |
| Week | 32,800 | 2,580,048 | 78.66 |
| 1 Month | 23,182 | 1,736,318 | 74.9 |
| 6 Month | 47,333 | 3,001,407 | 63.41 |
Nidan Laboratories And Healthcare Result Highlights
Nidan Laboratories And Healthcare Synopsis
NSE-Medical-Services
Nidan Laboratories is involved in the business activities of Other Hospital and Medical Care Activities. Company’s Total Operating Revenue is Rs. 24.27 Cr. and Equity Capital is Rs. 13.90 Cr. for the Year ended 31/03/2023. Nidan Laboratories And Healthcare Ltd. is a Public Limited Listed company incorporated on 05/12/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L33111MH2000PLC129883 and registration number is 129883.| Market Cap | 47 |
| Sales | 24 |
| Shares in Float | 0.60 |
| No of funds | |
| Yield |
| Book Value | 0.71 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 6 |
| Alpha | -0.08 |
| Beta | 0.9 |
Nidan Laboratories And Healthcare Shareholding Pattern
| Owner Name | Mar-24 | Sep-23 |
|---|---|---|
| Promoters | 57.04% | 62.79% |
| Individual Investors | 39.33% | 33.22% |
| Others | 3.63% | 3.99% |
Nidan Laboratories And Healthcare Management
| Name | Designation |
|---|---|
| Mr. Edwin Francis Dabre | Executive Director |
| Mrs. Tejal Anil Jayakar | Executive Director & CFO |
| Mr. Krupesh Deepak Thakur | Non Executive Director |
| Mr. Nilesh Ghanshyam Bide | Ind. Non-Executive Director |
| Mr. Abhinay Shashikant Nerurkar | Ind. Non-Executive Director |
| Dr. Abhijeet Dhanegaonkar | Ind. Non-Executive Director |
Nidan Laboratories And Healthcare Forecast
Price Estimates
Nidan Laboratories And Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-23 | Audited Results | |
| 2023-05-26 | Audited Results | |
| 2022-11-11 | Quarterly Results |
Nidan Laboratories And Healthcare FAQs
What is Share Price of Nidan Laboratories And Healthcare ?
Nidan Laboratories And Healthcare share price is ₹33 As on 18 September, 2024 | 02:23
What is the Market Cap of Nidan Laboratories And Healthcare ?
The Market Cap of Nidan Laboratories And Healthcare is ₹46.6 Cr As on 18 September, 2024 | 02:23
What is the P/E ratio of Nidan Laboratories And Healthcare ?
The P/E ratio of Nidan Laboratories And Healthcare is As on 18 September, 2024 | 02:23
What is the PB ratio of Nidan Laboratories And Healthcare ?
The PB ratio of Nidan Laboratories And Healthcare is 0.7 As on 18 September, 2024 | 02:23